Capula Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Capula Management's REGN Position: Q3 2026 in Review
Capula Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 276 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #867 among its holdings. This is a return to the name: Capula Management previously reported a position in REGN as recently as Q3 2025.
Capula Management first reported a position in REGN in Q1 2021 and has held it in 9 quarters since. The position peaked at $4.39M in Q1 2021. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Capula Management held 276 shares of Regeneron Pharmaceuticals worth $209K as of Q3 2026.
- Regeneron Pharmaceuticals was a new Capula Management position in Q3 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Capula Management's portfolio in Q3 2026, its #867 holding.
- Capula Management first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
- Capula Management's Regeneron Pharmaceuticals position peaked at $4.39M in Q1 2021.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Capula Management's 13F filing for Q3 2026, filed 16 Nov 2026.